Publication: 3327

Midostaurin in patients with acute myeloid leukemia and FLT3-TKD mutations: a subanalysis from the RATIFY trial
      QxMD      Google Scholar   
Citation:
Blood Adv vol 4 (19) 4945-4954
Year:
2020
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
Accepted
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
10
Parents:
3000   3002   3101  
Children:
None
Program:
OGC
Primary Committee:
Leukemia
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U24CA196171  
Corr. Author:
 
Authors:
                                                                           
Networks:
CA043, GULFSOUTH, LAPS-IL036, LAPS-IL057, LAPS-MA036, LAPS-OH007, OH070   
Study
CALGB-10603
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords:
25, Myeloid Neoplasia